Selective Laser Trabeculoplasty or SLT is a laser procedure considered to be the standard of care in treatment for Primary Open Angle Glaucoma (POAG). The treatment is indicated to lower the Intra-Ocular Pressure (IOP) associated with the disease just as effectively as medication, ensuring greater health, time savings, financial benefits and fewer side-effects.
SLT is a breakthrough procedure which stimulates the body’s own natural defense and healing mechanisms to manage and reduce the IOP, with no laser induced damage, making the procedure repeatable and allowing the physician a greater choice of options to manage the disease.
LIGHTMED’s LIGHTLas SLT is the most versatile system of its kind, featuring highly advanced integrated technologies, and is available in multi-modular configurations for discerning physicians. Download FAQs on SLT treatment now.